Paul Schimmel

Paul Schimmel

Founder at
Reactive Biosciences, Inc.

Net worth: 1 M $ as of 2026-05-30

85 year
Health Technology
Commercial Services
Finance

Profile

Paul R.
Schimmel
was the founder of Reactive Biosciences, Inc. (founded 2021), Alkermes, Inc. (founded 1987), Metabolon, Inc. (founded 2000), Abide Therapeutics, Inc. (founded 2011; Director), aTyr Pharma, Inc. (founded 2005; Independent Director), Repligen Corp.
(founded 1981; Co-Chairman), Alnylam Pharmaceuticals, Inc. (founded 2002; Independent Director), Momenta Pharmaceuticals, Inc. (founded 2001; Director), and Sirtris Pharmaceuticals, Inc. (founded 2004; Director).
Dr. Schimmel is also the founder of Cubist Pharmaceuticals LLC..
Current positions include Director at KinDex Pharmaceuticals, Inc. and Tevard Biosciences, Inc., Professor at The Scripps Research Institute (since 1997) and Skaggs Institute For Chemical Biology, Member of the National Academy of Sciences, National Academy of Medicine (United States), National Academy of Inventors, American Academy of Arts & Sciences, American Philosophical Society, and National Academy of Medicine, Advisor at Longwood Fund Management LLC, and Venture Partner at CHP Management, Inc. Former positions include Chairman of the Biological Chemistry Division at the American Chemical Society, Director at Momenta, Inc., Independent Director at Tocagen, Inc. (2015–2020), Director at Avicena Group, Inc., Vividion Therapeutics, Inc., and Alkermes Plc, Professor at Massachusetts Institute of Technology, and Member of the Scientific Advisory Board at Illumina, Inc. Education includes a doctorate from Cornell University, a doctorate from Massachusetts Institute of Technology (1966), and undergraduate studies at Ohio Wesleyan University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-05-26 2,201,056 ( 2.24% ) 1 M $ 2026-05-30

Paul Schimmel active positions

CompaniesPositionStart
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
Private Equity Investor -
Corporate Officer/Principal -
Corporate Officer/Principal -
Director/Board Member -
Founder 2020-12-31
Corporate Officer/Principal -
░░░░░░░░ ░░░░░░░ ░░ ░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -

Former positions of Paul Schimmel

CompaniesPositionEnd
░░░░ ░░░░░░░ ░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░ ░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -
See the detail of Paul Schimmel's experience

Training of Paul Schimmel

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

75

1st degree connections

32

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies32

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Consumer Services

Health Technology

Commercial Services

Finance

Consumer Services

Consumer Services

Commercial Services

Commercial Services

Commercial Services

Commercial Services

Distribution Services

National Academy of Medicine

Finance

Health Technology

Health Technology

Health Technology

Commercial Services

Commercial Services

Skaggs Institute For Chemical Biology